A detailed history of Engineers Gate Manager LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 22,847 shares of ABBV stock, worth $4.18 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
22,847
Previous 10,012 128.2%
Holding current value
$4.18 Million
Previous $1.72 Million 162.73%
% of portfolio
0.09%
Previous 0.04%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $2.1 Million - $2.56 Million
12,835 Added 128.2%
22,847 $4.51 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $6.37 Million - $7.44 Million
-41,159 Reduced 80.43%
10,012 $1.72 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $3.51 Million - $4 Million
21,993 Added 75.38%
51,171 $9.32 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $2.47 Million - $2.78 Million
17,940 Added 159.64%
29,178 $4.52 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $263,840 - $305,433
-1,975 Reduced 14.95%
11,238 $1.68 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $1.75 Million - $2.18 Million
13,213 New
13,213 $1.78 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $412,717 - $494,956
-2,984 Reduced 66.24%
1,521 $245,000
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $308,548 - $353,885
2,299 Added 104.22%
4,505 $605,000
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $97,985 - $124,571
-712 Reduced 24.4%
2,206 $338,000
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $1.82 Million - $2.25 Million
-13,757 Reduced 82.5%
2,918 $473,000
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $1.44 Million - $1.83 Million
13,445 Added 416.25%
16,675 $2.26 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $5.44 Million - $6.17 Million
-51,114 Reduced 94.06%
3,230 $348,000
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $5.72 Million - $6.37 Million
54,344 New
54,344 $6.12 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $16.9 Million - $22.8 Million
-210,213 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $17.1 Million - $20.1 Million
199,355 Added 1836.02%
210,213 $18.4 Million
Q2 2020

Aug 17, 2020

SELL
$73.37 - $98.18 $1.09 Million - $1.46 Million
-14,865 Reduced 57.79%
10,858 $1.07 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $1.14 Million - $1.72 Million
17,633 Added 217.96%
25,723 $1.96 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $583,531 - $730,122
8,090 New
8,090 $716,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $324B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.